41 results on '"van Engeland, M."'
Search Results
2. STOOL-BASED TESTING TO REDUCE THE NUMBER OF UNNECESSARY SURVEILLANCE COLONOSCOPIES: THE MOCCAS STUDY
3. P66.09 Differential Orthopedia Homeobox (OTP) Expression in Pulmonary Carcinoids is Regulated Through Methylation
4. Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers
5. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population
6. Molecular profiling of longitudinally observed small colorectal polyps: A cohort study
7. NDRG4, an early detection marker for colorectal cancer, is specifically expressed in enteric neurons
8. Body size, physical activity, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk
9. Resistance to sunitinib in renal cell carcinoma: From molecular mechanisms to predictive markers and future perspectives
10. Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis
11. Dietary acrylamide intake and the risk of colorectal cancer with specific mutations in KRAS and APC
12. Long-term dietary sodium, potassium and fluid intake; exploring potential novel risk factors for renal cell cancer in the Netherlands Cohort Study on diet and cancer
13. Dietary heme iron and the risk of colorectal cancer with specific mutations in KRAS and APC
14. A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis
15. Physical Activity, Occupational Sitting Time, and Colorectal Cancer Risk in the Netherlands Cohort Study
16. Genomweite DNA Methylierungs-Analyse in Mammakarzinomzellen zur Identifikation prädiktiver Biomarker für PARP Inhibitoren
17. Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis
18. Abstract 637: Dietary heme iron and risk of colorectal cancer with specific mutations in colorectal cancer key genes
19. DCC (deleted in colorectal carcinoma)
20. Body Size and Colorectal Cancer Risk After 16.3 Years of Follow-up: An Analysis From the Netherlands Cohort Study
21. DNA copy number alterations in flat colorectal adenomas
22. The influence of choice of therapy on quality of life in patients with neurogenic thoracic outlet syndrome
23. Childhood and adolescent energy restriction and subsequent colorectal cancer risk: results from the Netherlands Cohort Study
24. Cytoskeletal and nuclear changes during apoptosis
25. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events
26. Alcohol Consumption and Mutations or Promoter Hypermethylation of the von Hippel-Lindau Gene in Renal Cell Carcinoma
27. Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype
28. E2F s mediate a fundamental cell-cycle deregulation in high-grade serous ovarian carcinomas
29. Poorer outcome in stromal HIF-2α- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis
30. MLH1 promotor hypermethylation, BRAF and K-ras mutation analysis on tumours suspected from Lynch Syndrome to prioritize mismatch repair gene testing
31. Genetic variants of folate metabolizing enzymes and epigenetic regulation genes and sporadic colorectal cancer risk
32. Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer
33. Defects in DNA mismatch repair do not account for early-onset basal cell carcinoma
34. Detection of DNA methylation in inflammatory breast tumours by a multiplex nested methylation-specific PCR
35. RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer
36. Clonal analysis favours a monoclonal origin for serous borderline tumours with peritoneal implants
37. APC, beta-catenin, and E-cadherin and the development of recurrent endometrial carcinoma
38. Defective mismatch repair and the development of recurrent endometrial carcinoma
39. APC, β-catenin, and E-cadherin and the development of recurrent endometrial carcinoma
40. Alendronate in the Prevention of Bone Loss After a Fracture of the Lower Leg
41. ‘Components separation technique’: a useful method for repair of (contaminated) abdominal wall defects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.